首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
Nivolumab/osimertinibInterstitial lung disease: case report
被引:0
|
作者
:
机构
:
来源
:
Reactions Weekly
|
2017年
/ 1666卷
/ 1期
关键词
:
D O I
:
10.1007/s40278-017-35067-4
中图分类号
:
学科分类号
:
摘要
:
引用
收藏
页码:225 / 225
相关论文
共 50 条
[41]
Nivolumab/pembrolizumabInterstitial lung disease: 14 case reports
Reactions Weekly,
2019,
1776
(1)
: 333
-
333
[42]
Goodpasture's disease in a patient with advanced lung cancer treated with nivolumab: An autopsy case report
Takahashi, Naoki
论文数:
0
引用数:
0
h-index:
0
机构:
Kochi Red Cross Hosp, Dept Internal Med, 2-13-51 Shin Honmachi, Kochi 7808562, Japan
Kochi Red Cross Hosp, Dept Internal Med, 2-13-51 Shin Honmachi, Kochi 7808562, Japan
Takahashi, Naoki
Tsuji, Kazuya
论文数:
0
引用数:
0
h-index:
0
机构:
Kochi Red Cross Hosp, Dept Internal Med, 2-13-51 Shin Honmachi, Kochi 7808562, Japan
Kochi Red Cross Hosp, Dept Internal Med, 2-13-51 Shin Honmachi, Kochi 7808562, Japan
Tsuji, Kazuya
Tamiya, Hiroyuki
论文数:
0
引用数:
0
h-index:
0
机构:
Kochi Red Cross Hosp, Dept Internal Med, 2-13-51 Shin Honmachi, Kochi 7808562, Japan
Kochi Red Cross Hosp, Dept Internal Med, 2-13-51 Shin Honmachi, Kochi 7808562, Japan
Tamiya, Hiroyuki
Shinohara, Tsutomu
论文数:
0
引用数:
0
h-index:
0
机构:
Natl Hosp Org Kochi Hosp, Dept Clin Invest, 1-2-25 Asakuranishimachi, Kochi 7808077, Japan
Kochi Red Cross Hosp, Dept Internal Med, 2-13-51 Shin Honmachi, Kochi 7808562, Japan
Shinohara, Tsutomu
Kuroda, Naoto
论文数:
0
引用数:
0
h-index:
0
机构:
Kochi Red Cross Hosp, Dept Diagnost Pathol, 2-13-51 Shin Honmachi, Kochi 7808562, Japan
Kochi Red Cross Hosp, Dept Internal Med, 2-13-51 Shin Honmachi, Kochi 7808562, Japan
Kuroda, Naoto
Takeuchi, Eiji
论文数:
0
引用数:
0
h-index:
0
机构:
Kochi Red Cross Hosp, Dept Internal Med, 2-13-51 Shin Honmachi, Kochi 7808562, Japan
Kochi Red Cross Hosp, Dept Internal Med, 2-13-51 Shin Honmachi, Kochi 7808562, Japan
Takeuchi, Eiji
LUNG CANCER,
2018,
122
: 22
-
24
[43]
Vitiligo in a patient with lung adenocarcinoma treated with nivolumab: A case report
Uenami, Takeshi
论文数:
0
引用数:
0
h-index:
0
机构:
Toneyama Natl Hosp, Dept Thorac Oncol, 5-1-1 Toneyama, Toyonaka, Osaka 5608552, Japan
Toneyama Natl Hosp, Dept Thorac Oncol, 5-1-1 Toneyama, Toyonaka, Osaka 5608552, Japan
Uenami, Takeshi
Hosono, Yuki
论文数:
0
引用数:
0
h-index:
0
机构:
Toneyama Natl Hosp, Dept Thorac Oncol, 5-1-1 Toneyama, Toyonaka, Osaka 5608552, Japan
Toneyama Natl Hosp, Dept Thorac Oncol, 5-1-1 Toneyama, Toyonaka, Osaka 5608552, Japan
Hosono, Yuki
Ishijima, Mikako
论文数:
0
引用数:
0
h-index:
0
机构:
Toneyama Natl Hosp, Dept Thorac Oncol, 5-1-1 Toneyama, Toyonaka, Osaka 5608552, Japan
Toneyama Natl Hosp, Dept Thorac Oncol, 5-1-1 Toneyama, Toyonaka, Osaka 5608552, Japan
Ishijima, Mikako
Kanazu, Masaki
论文数:
0
引用数:
0
h-index:
0
机构:
Toneyama Natl Hosp, Dept Thorac Oncol, 5-1-1 Toneyama, Toyonaka, Osaka 5608552, Japan
Toneyama Natl Hosp, Dept Thorac Oncol, 5-1-1 Toneyama, Toyonaka, Osaka 5608552, Japan
Kanazu, Masaki
Akazawa, Yuki
论文数:
0
引用数:
0
h-index:
0
机构:
Toneyama Natl Hosp, Dept Thorac Oncol, 5-1-1 Toneyama, Toyonaka, Osaka 5608552, Japan
Toneyama Natl Hosp, Dept Thorac Oncol, 5-1-1 Toneyama, Toyonaka, Osaka 5608552, Japan
Akazawa, Yuki
Yano, Yukihiro
论文数:
0
引用数:
0
h-index:
0
机构:
Toneyama Natl Hosp, Dept Thorac Oncol, 5-1-1 Toneyama, Toyonaka, Osaka 5608552, Japan
Toneyama Natl Hosp, Dept Thorac Oncol, 5-1-1 Toneyama, Toyonaka, Osaka 5608552, Japan
Yano, Yukihiro
Mori, Masahide
论文数:
0
引用数:
0
h-index:
0
机构:
Toneyama Natl Hosp, Dept Thorac Oncol, 5-1-1 Toneyama, Toyonaka, Osaka 5608552, Japan
Toneyama Natl Hosp, Dept Thorac Oncol, 5-1-1 Toneyama, Toyonaka, Osaka 5608552, Japan
Mori, Masahide
Yamaguchi, Toshihiko
论文数:
0
引用数:
0
h-index:
0
机构:
Toneyama Natl Hosp, Dept Thorac Oncol, 5-1-1 Toneyama, Toyonaka, Osaka 5608552, Japan
Toneyama Natl Hosp, Dept Thorac Oncol, 5-1-1 Toneyama, Toyonaka, Osaka 5608552, Japan
Yamaguchi, Toshihiko
Yokota, Soichiro
论文数:
0
引用数:
0
h-index:
0
机构:
Toneyama Natl Hosp, Dept Thorac Oncol, 5-1-1 Toneyama, Toyonaka, Osaka 5608552, Japan
Toneyama Natl Hosp, Dept Thorac Oncol, 5-1-1 Toneyama, Toyonaka, Osaka 5608552, Japan
Yokota, Soichiro
LUNG CANCER,
2017,
109
: 42
-
44
[44]
Atezolizumab/nivolumab/pembrolizumabInterstitial lung disease: 5 case reports
Reactions Weekly,
2022,
1929
(1)
: 115
-
115
[45]
Nivolumab/osimertinibHepatotoxicity and interstitial lung disease: 3 case reports
Reactions Weekly,
2017,
1668
(1)
: 309
-
309
[46]
Large cell neuroendocrine carcinoma of the lung that responded to nivolumab: A case report
Sato, Michiko Takimoto
论文数:
0
引用数:
0
h-index:
0
机构:
Oji Gen Hosp, Dept Resp Med, 3-4-8 Wakakusa Cho, Tomakomai, Hokkaido 0538506, Japan
Oji Gen Hosp, Dept Resp Med, 3-4-8 Wakakusa Cho, Tomakomai, Hokkaido 0538506, Japan
Sato, Michiko Takimoto
Ikezawa, Yasuyuki
论文数:
0
引用数:
0
h-index:
0
机构:
Oji Gen Hosp, Dept Resp Med, 3-4-8 Wakakusa Cho, Tomakomai, Hokkaido 0538506, Japan
Oji Gen Hosp, Dept Resp Med, 3-4-8 Wakakusa Cho, Tomakomai, Hokkaido 0538506, Japan
Ikezawa, Yasuyuki
Sato, Mineyoshi
论文数:
0
引用数:
0
h-index:
0
机构:
Oji Gen Hosp, Dept Resp Med, 3-4-8 Wakakusa Cho, Tomakomai, Hokkaido 0538506, Japan
Oji Gen Hosp, Dept Resp Med, 3-4-8 Wakakusa Cho, Tomakomai, Hokkaido 0538506, Japan
Sato, Mineyoshi
Suzuki, Akira
论文数:
0
引用数:
0
h-index:
0
机构:
Oji Gen Hosp, Dept Pathol, Tomakomai, Hokkaido 0538506, Japan
KKR Sapporo Med Ctr, Dept Pathol, Sapporo, Hokkaido 0620931, Japan
Oji Gen Hosp, Dept Resp Med, 3-4-8 Wakakusa Cho, Tomakomai, Hokkaido 0538506, Japan
Suzuki, Akira
Kawai, Yasutaka
论文数:
0
引用数:
0
h-index:
0
机构:
Oji Gen Hosp, Dept Resp Med, 3-4-8 Wakakusa Cho, Tomakomai, Hokkaido 0538506, Japan
Oji Gen Hosp, Dept Resp Med, 3-4-8 Wakakusa Cho, Tomakomai, Hokkaido 0538506, Japan
Kawai, Yasutaka
MOLECULAR AND CLINICAL ONCOLOGY,
2020,
13
(01)
: 43
-
47
[47]
Carboplatin/nivolumab/paclitaxelImmune-related lung injury: case report
Reactions Weekly,
2021,
1880
(1)
: 113
-
113
[48]
Ipilimumab/nivolumab/Nivolumab/Nivolumab/relatlimabVarious toxicities: case report
Reactions Weekly,
2025,
2056
(1)
: 265
-
265
[49]
Nivolumab/pembrolizumabRheumatoid vasculitis, acute heart failure with reduced ejection fraction and interstitial lung disease: case report
Reactions Weekly,
2021,
1878
(1)
: 415
-
415
[50]
Nivolumab/pembrolizumabInterstitial lung disease and active neurosyphilis: 2 case reports
Reactions Weekly,
2019,
1768
(1)
: 256
-
256
←
1
2
3
4
5
→